Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
The systems were then heated for 100 ps by incrementing the temperature from 0 to 300 K under a constant pressure of 1 atm and periodic boundary conditions with a timestep of 1 fs
Upper Arm People choosing to avoid frequent visits to the healthcare provider often opt for self administration of peptides via subcutaneous injections in the upper arm due to the ease and convenience of the location
GC18256 PF-06281355 PF-06281355 PF-06281355 is a selective 2-thiouracil mechanism-based MPO inhibitor, used for treatment of vasculitic diseases
DOX (Doxorubicin), CP (Cyclophosphamide), PARP-1 (Poly (ADP-Ribose) Polymerase 1), Bcl-2 (B-Cell Lymphoma 2), AC (Anticancer Chemotherapy), IL-3 (Interleukin-3), NF-B (Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells), COX-2 (Cyclooxygenase-2), IL-3 (Interleukin-3), CYP (Cyclophosphamide), 5-FU (5-Fluorouracil), MTX (Methotrexate), SOD (Superoxide Dismutase), CAT (Catalase), GPx (Glutathione Peroxidase), GST (Glutathione S-Transferase), MDA (Malondialdehyde), ROS (Reactive Oxygen Species)
US$ 29.94
US$ 27.41
US$ 20.47
US$ 25.66
US$ 21.11
US$ 20.60
US$ 25.65
US$ 25.20
US$ 25.15
